Eiko Lifesciences Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002696,
    "name": "Eiko Lifescience",
    "stock_name": "Eiko Lifescience",
    "full_name": "Eiko Lifesciences Ltd",
    "name_url": "stocks-analysis/eiko-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "51.22",
    "chg": -1.02,
    "chgp": "-1.95%",
    "dir": -1,
    "prev_price": "52.24",
    "mcapval": "74.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540204,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 5,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE666Q01016",
    "curr_date": "Sep 25, 03:30 PM",
    "curr_time": "20:15 PM",
    "last_traded_at": "Sep 25, 03:30 PM IST",
    "bse_nse_vol": "18.75 k",
    "exc_status": "Active",
    "traded_date": "Sep 25, 2026",
    "traded_date_str": "2026 09 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/eiko-lifescience-1002696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-4196306",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EikoLifescience_mojoScore_4196306.png",
        "date": "2026-09-17 10:10:04",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with the most recent insights into the company’s performance and outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 43 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eiko-lifesciences-ltd-stock-hits-52-week-low-at-rs43-amid-market-downturn-4193674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EikoLifescience_priceRelatedfactors_4193674.png",
        "date": "2026-09-15 13:35:40",
        "description": "For the fourth consecutive session, Eiko Lifesciences Ltd has closed lower, culminating in a fresh 52-week low of Rs 43 on 15 Sep 2026. This marks a 33.3% decline from its 52-week high of Rs 64.44, underscoring sustained selling pressure despite some positive financial signals."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-4182479",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EikoLifescience_mojoScore_4182479.png",
        "date": "2026-09-04 10:10:27",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-4166811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EikoLifescience_mojoScore_4166811.png",
        "date": "2026-08-24 10:10:29",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 44.75 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eiko-lifesciences-ltd-falls-to-52-week-low-of-rs4475-amid-continued-downtrend-4157969",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EikoLifescience_priceRelatedfactors_4157969.png",
        "date": "2026-08-17 10:20:36",
        "description": "A sharp decline over the past two sessions has dragged Eiko Lifesciences Ltd to a fresh 52-week low of Rs 44.75 on 17 Aug 2026, marking a 7.04% intraday drop and extending its losing streak to five sessions. This downturn contrasts with the broader market, where the Sensex remains above its 50-day moving average despite a modest fall of 0.57% on the day."
      },
      {
        "title": "Eiko Lifesciences Ltd Reports Positive Quarterly Growth Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eiko-lifesciences-ltd-reports-positive-quarterly-growth-amid-market-challenges-4150839",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EikoLifescience_fintrenddot_4150839.png",
        "date": "2026-08-13 08:00:31",
        "description": "Eiko Lifesciences Ltd, a micro-cap player in the Specialty Chemicals sector, reported a notably positive quarterly performance for June 2026, with robust revenue growth and record profitability metrics. Despite a downgrade in its Mojo Grade from Hold to Sell, the company’s latest financials reveal encouraging signs of operational strength, though challenges remain in its broader market performance and valuation."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-4150159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EikoLifescience_mojoScore_4150159.png",
        "date": "2026-08-12 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-4131274",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EikoLifescience_mojoScore_4131274.png",
        "date": "2026-08-01 10:10:04",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-4131286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EikoLifescience_mojoScore_4131286.png",
        "date": "2026-08-01 10:10:04",
        "description": "Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 502,
    "sid": "1002696",
    "stock_news_url": "https://www.marketsmojo.com/news/eiko-lifesciences-1002696"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "22-Sep-2026",
      "details": "The Proceedings of the 49th Annual General Meeting (AGM) of Eiko LifeSciences Limited held on Tuesday 22nd September 2026 at 04:00 P.M. IST through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM) is attached herewith.",
      "source": "BSE"
    },
    {
      "caption": "Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 (The Listing Regulations)",
      "datetime": "27-Aug-2026",
      "details": "The Company has sent a letter providing the weblink and QR Code for accessing the Notice convening the 49th Annual General Meeting (\"AGM\") and the Annual Report of the Company for the Financial Year 2025-26 to the following categories of shareholders:",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "25-Aug-2026",
      "details": "Newspaper Advertisement for 49th Annual General Meeting (AGM) of the Company scheduled to be held on Tuesday 22nd day of September 2026 at 04:00 P.M. IST through Video Conference / Other Audio-Visual Means",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has declared <strong>2%</strong> dividend, ex-date: 20 Sep 17",
          "dt": "2017-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has announced <strong>2:3</strong> rights issue, ex-date: 07 Jul 23",
          "dt": "2023-07-07",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-09-17 10:10:04

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with the most recent insights into the company’s performance and outlook.

Read full news article

Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 43 as Sell-Off Deepens

2026-09-15 13:35:40

For the fourth consecutive session, Eiko Lifesciences Ltd has closed lower, culminating in a fresh 52-week low of Rs 43 on 15 Sep 2026. This marks a 33.3% decline from its 52-week high of Rs 64.44, underscoring sustained selling pressure despite some positive financial signals.

Read full news article

Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-09-04 10:10:27

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Eiko Lifesciences Ltd is Rated Sell

2026-08-24 10:10:29

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 44.75 as Sell-Off Deepens

2026-08-17 10:20:36

A sharp decline over the past two sessions has dragged Eiko Lifesciences Ltd to a fresh 52-week low of Rs 44.75 on 17 Aug 2026, marking a 7.04% intraday drop and extending its losing streak to five sessions. This downturn contrasts with the broader market, where the Sensex remains above its 50-day moving average despite a modest fall of 0.57% on the day.

Read full news article

Eiko Lifesciences Ltd Reports Positive Quarterly Growth Amid Market Challenges

2026-08-13 08:00:31

Eiko Lifesciences Ltd, a micro-cap player in the Specialty Chemicals sector, reported a notably positive quarterly performance for June 2026, with robust revenue growth and record profitability metrics. Despite a downgrade in its Mojo Grade from Hold to Sell, the company’s latest financials reveal encouraging signs of operational strength, though challenges remain in its broader market performance and valuation.

Read full news article

Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-08-12 10:10:03

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-08-01 10:10:04

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-08-01 10:10:04

Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News